Susanne Schorsch – Startup Investor Profile

Susanne Schorsch is a Partner at Amadeus Capital with a focus on European early-growth deep tech investments. She has led over 20 investments in deeptech, particularly in health and biotech sectors. Susanne’s previous experience includes being a Partner at Verve Ventures, where she actively contributed to the success of companies like CREAL, MemoTherapeutics, and Nagi Bioscience. Some of her notable investments include Alaya (acquired by Benevity) and Onward and Astrocast (both went public in 2021). With a background in international business at BASF, Susanne brings a wealth of experience in strategy and innovation. She has a strong educational background, having completed executive programs in Venture Capital and Innovation at UC Berkeley. Susanne holds an MSc and BSc in Industrial Engineering from the Karlsruhe Institute of Technology and is an alumna of the University of Pennsylvania’s Wharton School.

Location:

Country: Switzerland

Investment Regions: EU

Investment Stages: pre-seed, seed

Website:

AI Reasoning: Searches found only a speaker listing (ETH AI Center, 2024) mentioning Susanne Schorsch at Amadeus Capital but no public record of recent investments or dated deal announcements. Known past investments include Alaya (acquired by Benevity), Onward and Astrocast (public 2021), CREAL, MemoTherapeutics, and Nagi Bioscience; however, no investment dates within the last 12 months were found. Given lack of verifiable recent investment activity, classify as not-found.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.